Development and Validation of a Novel ECL Method for the Quantitative Detection of Complement C3 in Human Serum

complement-fragments-c3a-and-c5a-attracting-immune-cells-a-colorful-visualization-of-inflammation-induction_adobestock_1777508006

Discover a validated approach for accurately measuring complement C3 in human serum.

Reliable quantification of complement proteins is essential for understanding immune responses and supporting therapeutic development. This poster highlights the development and validation of a highly sensitive electrochemiluminescence (ECL) immunoassay for the quantitative measurement of complement C3, demonstrating robust analytical performance for use in clinical research.

Key highlights include:

  • Development and validation of a sensitive sandwich ECL immunoassay for complement C3
  • Evaluation of assay sensitivity, accuracy, precision, and selectivity
  • Assessment of assay stability under multiple storage and handling conditions
  • Strategies for overcoming analytical challenges associated with high-abundance complement proteins
  • Potential applications for complement C3 analysis in additional human sample types

As complement biomarkers continue to play an expanding role in immunology and drug development, robust analytical methods are critical for generating reliable data. Learn how this validated ECL immunoassay supports accurate complement C3 measurement for research and clinical applications.

Complete the form below to access this poster.

Development and Validation of a Novel ECL Method for the Quantitative Detection of Complement C3 in Human Serum

To learn more about how Eurofins processes and protects your personal data and your rights, please read our Privacy Notice.